Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Artificial intelligence-enabled microfluidic analysis of ciliary beat defects for drug discovery, biomedicine, and disease screening

Project description

AI to analyse and detect ciliary beat defects

Rhythmically beating ciliated cells play a crucial role in various physiological functions, particularly in the airways and reproductive system. Defects in ciliary beating can lead to debilitating diseases, such as chronic obstructive pulmonary disease, which is currently incurable. However, the complexity of ciliary beat patterns makes large-scale analysis challenging. The ERC-funded Ai4Cilia project aims to develop an automated, microfluidic, AI-powered assay to detect and classify ciliary beat abnormalities. By integrating microfluidic technology and AI, the project will offer a solution for detecting and classifying ciliary beat defects, providing significant benefits for drug discovery, disease screening, and biomedicine.

Objective

In Ai4Cilia (“Artificial intelligence for Cilia”), we will develop an automated microfluidic AI-powered assay of ciliated cells to detect and classify ciliary beat abnormalities for drug discovery, biomedicine, and disease screening. Rhythmically beating ciliated cells perform important physiological functions in the airways and the reproductive system. Defects of ciliary beat contribute to debilitating diseases, such as to-date uncurable chronic obstructive pulmonary disease (COPD), and underdiagnosed causes of infertility. In the context of our ERC StG MecCOPD, we recently showed that standard video-microscopy recordings of ciliary beat can be used to extract quantitative metrics that clearly identify disease-specific ciliary dysfunction. Therefore, since ciliary beat can be observed in vitro and in minimally invasive biopsies, it could provide a much-needed readout for drug development and improved diagnosis. However, since ciliary beat patterns are highly complex, it takes specialists to analyze them and hence this information is rarely exploited in praxis. To establish ciliary beat as a common readout, we developed a microfluidic platform that standardizes data acquisition from ciliated cells and uses AI for detecting and classifying ciliary beat defects. To bring this approach to the next level and towards market entry, we will address three key objectives in Ai4Cilia to demonstrate (1) hardware feasibility by validating human ciliated cell capture and data acquisition in our microfluidic chip; (2) software feasibility by training our AI algorithm to detect disease-specific ciliary defects and validate sensitivity and specificity of our assay; and (3) business feasibility by assessing customer needs in biomedical and clinical research to define the most efficient go-to-market strategy. We believe this strategy will make ciliary beat a highly sensitive and robust readout for respiratory and reproductive (dys)function in biomedical and clinical research.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-POC

See all projects funded under this call

Host institution

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Net EU contribution
€ 150 000,00
Address
INGOLSTADTER LANDSTRASSE 1
85764 Neuherberg
Germany
Region
Bayern Oberbayern München, Landkreis
Activity type
Research Organisations
Links
Total cost
No data

Beneficiaries (1)